Clinical Trials Browser

Interventional × Congenital Abnormalities × Epirubicin × Clear all

NCT04668365 2025-04-25

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Phase 2 Suspended

Congenital Abnormalities, Lymphoma, Large B-Cell, Diffuse